Literature DB >> 8505310

Thrombin is inactivated by mast cell secretory granule chymase.

G Pejler1, A Karlström.   

Abstract

In a recent paper we demonstrated that cultures of murine adherent peritoneal cells expressed cell surface-associated serine protease activity that specifically inactivated thrombin by cleaving the enzyme into defined proteolytic fragments (Pejler, G., and Seljelid, R. (1992) J. Biol. Chem. 267, 3136-3142). In the present report, the purification and further characterization of the thrombin-inactivating serine protease is described. The serine protease is shown to be expressed by mast cells. Purification of the thrombin-inactivating serine protease by a combination of anion-exchange chromatography and Superdex 75 chromatography showed that the enzyme had an apparent molecular mass of 28 kDa. N-terminal sequence analysis of the purified protein demonstrated 100% identity of the thrombin-inactivating serine protease with the secretory granule chymases: murine mast cell protease 3 and murine mast cell protease 4. The serine protease showed chymotrypsin-like substrate specificity. The thrombin-inactivating activity was markedly enhanced by optimal concentrations of heparin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505310

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Mast cell proteoglycans.

Authors:  Elin Rönnberg; Fabio R Melo; Gunnar Pejler
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

2.  Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.

Authors:  Lan Lin; Eric Bankaitis; Lisa Heimbach; Ning Li; Magnus Abrink; Gunnar Pejler; Lijia An; Luis A Diaz; Zena Werb; Zhi Liu
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 3.  Novel Insight into the in vivo Function of Mast Cell Chymase: Lessons from Knockouts and Inhibitors.

Authors:  Gunnar Pejler
Journal:  J Innate Immun       Date:  2020-06-04       Impact factor: 7.349

4.  Interaction of heparin with synthetic peptides corresponding to the C-terminal domain of intestinal mucins.

Authors:  G Xu; G G Forstner; J F Forstner
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

5.  Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen.

Authors:  Alicia Prieto-García; Dominick Zheng; Roberto Adachi; Wei Xing; William S Lane; Kyungmee Chung; Paul Anderson; Philip M Hansbro; Mariana Castells; Richard L Stevens
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

6.  Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.

Authors:  G Pejler
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

7.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Authors:  G Pejler; K Söderström; A Karlström
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

9.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

Review 10.  The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis.

Authors:  Devandir Antonio de Souza Junior; Ana Carolina Santana; Elaine Zayas Marcelino da Silva; Constance Oliver; Maria Celia Jamur
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.